Abbott Laboratories's total assets for Q1 2026 were $110.43B, an increase of 27.35% from the previous quarter. ABT total liabilities were $57.73B for the fiscal quarter, a 70.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.